Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
SRU Biosystems, Inc. was a company focused on the development and commercialization of innovative label-free detection systems. Their core technology, BIND® (Biomolecular Interaction Detection), utilized advanced optical biosensor technology for real-time monitoring of molecular interactions. These systems were applied in life science research, drug discovery, and diagnostics. Key applications included protein-protein interactions, antibody characterization, and small molecule screening. SRU Biosystems was founded in 2000 and was acquired by Sumitomo Bakelite Co. Ltd. in November 2010. Its technologies and expertise have since been integrated into Sumitomo Bakelite's life science portfolio.
Primarily served as the center for research and development of its BIND® technology, manufacturing of biosensor consumables, corporate administration, and sales/marketing operations.
Standard lab and office facilities suitable for biotech R&D and light manufacturing within a commercial park. No specific unique architectural highlights are publicly documented.
As a technology-focused biotech company, the culture was likely innovative, research-driven, and collaborative, with a focus on scientific advancement and product development in a competitive field.
The Woburn, MA location placed SRU Biosystems within a prominent life sciences cluster, offering access to talent, research institutions, and potential partners, which was crucial for its R&D and commercialization efforts.
Prior to its acquisition by Sumitomo Bakelite in 2010, SRU Biosystems marketed its BIND® technology and products to the global life sciences research community. Its primary markets likely included North America, Europe, and key research hubs in Asia. Global reach was achieved through a combination of direct sales efforts, a network of distributors, and collaborations with international research institutions and pharmaceutical companies. The universal applicability of its label-free detection technology gave it relevance across diverse international markets focused on drug discovery and diagnostics.
14 Gill Street, Suite H
Woburn
Massachusetts
USA
Address: N/A
N/A - Operations were largely centralized at the Woburn headquarters.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SRU Biosystems' leadership includes:
SRU Biosystems has been backed by several prominent investors over the years, including:
SRU Biosystems was acquired by Sumitomo Bakelite in November 2010. Consequently, there have been no executive new hires or exits attributable to SRU Biosystems as an independent company in the last 12 months. Any leadership changes concerning its former technologies or assets would occur within the Sumitomo Bakelite organization.
Discover the tools SRU Biosystems uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While SRU Biosystems was an active independent company (pre-2010 acquisition), its email formats likely followed common corporate structures for technology companies. The most probable formats would have been [first_initial][last]@[srubiosystems.com] or [first].[last]@[srubiosystems.com], using their domain srubiosystems.com.
[first_initial][last]@srubiosystems.com
Format
jdoe@srubiosystems.com (example format)
Example
0 (The company was acquired, and the domain srubiosystems.com is no longer actively used for email by a standalone SRU Biosystems entity. Emails to this domain would likely bounce or be undeliverable.)%
Success rate
Business Wire • November 8, 2010
Sumitomo Bakelite Co., Ltd. announced its definitive agreement to acquire SRU Biosystems, Inc. This strategic acquisition was aimed at strengthening Sumitomo Bakelite's presence and capabilities in the life science and diagnostics market by integrating SRU's label-free BIND® detection technology....more
PR Newswire • September 30, 2008
SRU Biosystems announced that its BIND® System was selected by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of rapid tests for biodetection agents. This collaboration highlighted the system's potential for critical applications in biodefense and infectious disease monitoring....more
FierceBiotech (reporting on company announcement) • June 28, 2007
SRU Biosystems successfully raised $10 million in a Series C financing round. Key investors included Harris & Harris Group, KGI Ventures, Intel Capital, Brooke Private Equity Advisors, and Sumitomo Corporation. The funds were allocated to advance product development, expand manufacturing capabilities, and bolster sales and marketing efforts for its BIND® platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SRU Biosystems, are just a search away.